Introducing Ultragenyx Pharmaceutical Inc, a visionary biopharmaceutical company dedicated to revolutionizing the field of rare and ultrarare disease treatments. Today, we proudly unveil our highly anticipated second annual ESG report, …
Introducing Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a leading biopharmaceutical powerhouse dedicated to revolutionizing healthcare for those affected by rare and ultrarare diseases. Today, we proudly unveil our highly anticipated second …
